#JustPublished!
Impact of surge in China #COVID19 cases on epidemiological situation in EU/EEA.
The number of cases has reached a record high in China, peaking on 2.12.22. In the past three weeks, incidence has fallen, likely also due to a lower testing.
https://www.ecdc.europa.eu/en/news-events/impact-surge-china-covid-19-cases
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1610196071971528704
There continues to be a lack of reliable data on #COVID19 cases, hospital admissions, deaths as well as ICU capacity & occupancy in China.
High levels of infections are expected in the coming weeks due to low population immunity & the relaxation of measures.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1610196074861412352
The #SARSCov2 variants circulating in China are already circulating in the EU, and as such are not challenging for the immune response of EU/EEA citizens. In addition, EU/EEA citizens have relatively high immunisation and vaccination levels.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1610196077583425540
A surge in cases in China is not expected to impact the #COVID19 epidemiological situation in the EU/EEA, we are however constantly monitoring the situation with Member States, @EU_Commission & @WHO_Europe.
https://www.ecdc.europa.eu/en/news-events/impact-surge-china-covid-19-cases
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1610196082092564482
